PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume 42, Issue 12, Pages 1317-1326
Publisher
Wiley
Online
2015-09-24
DOI
10.1111/1440-1681.12493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colon cancer: Cancer stem cells markers, drug resistance and treatment
- (2014) Zuzana Kozovska et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
- (2014) S Hasegawa et al. BRITISH JOURNAL OF CANCER
- MicroRNAs: master regulators of drug resistance, stemness, and metastasis
- (2014) Umar Raza et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
- (2014) Laetitia Seguin et al. NATURE CELL BIOLOGY
- Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs
- (2013) Guan-hua Rao et al. ACTA PHARMACOLOGICA SINICA
- NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
- (2013) Wen-juan Wang et al. ACTA PHARMACOLOGICA SINICA
- Significance of mTOR Signaling and Its Inhibitor Against Cancer Stem-Like Cells in Colorectal Cancer
- (2013) Zerong Cai et al. ANNALS OF SURGICAL ONCOLOGY
- Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer
- (2013) Yi-Shiuan Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- LGR5 positivity defines stem-like cells in colorectal cancer
- (2013) Daniela Hirsch et al. CARCINOGENESIS
- Editorial (Hot Topic Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer)
- (2013) Jiezhong Chen CURRENT CANCER DRUG TARGETS
- Therapeutic Implications of mTOR Inhibitors in the Treatment of Gastric Cancer
- (2013) Zhaode Bu et al. CURRENT CANCER DRUG TARGETS
- Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma
- (2013) Daniel C. Cho et al. CURRENT CANCER DRUG TARGETS
- The PI3 Kinase Signaling Pathway in Prostate Cancer
- (2013) Aymen A. Elfiky et al. CURRENT CANCER DRUG TARGETS
- CD44 Expressed on Cancer-Associated Fibroblasts Is a Functional Molecule Supporting the Stemness and Drug Resistance of Malignant Cancer Cells in the Tumor Microenvironment
- (2013) Yumi Kinugasa et al. STEM CELLS
- Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker
- (2012) Meike Schneider et al. BMC CANCER
- Estrogen in obesity-associated colon cancer: friend or foe? Protecting postmenopausal women but promoting late-stage colon cancer
- (2012) Jiezhong Chen et al. CANCER CAUSES & CONTROL
- CD133 as a target for colon cancer
- (2012) Veronica Catalano et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Co-expression of CD133+/CD44+in human colon cancer and liver metastasis
- (2012) Antonia Bellizzi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- LGR5-Positive Colon Cancer Stem Cells Interconvert with Drug-Resistant LGR5-Negative cells and are Capable of Tumor Reconstitution
- (2012) Shinta Kobayashi et al. STEM CELLS
- Novel strategies targeting cancer stem cells through phytochemicals and their analogs
- (2012) Prasad Dandawate et al. Drug Delivery and Translational Research
- Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability
- (2011) W Gu et al. CANCER GENE THERAPY
- The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse
- (2011) Anna Merlos-Suárez et al. Cell Stem Cell
- Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cells
- (2011) Ke-li Chen et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
- (2011) R. Kanai et al. CLINICAL CANCER RESEARCH
- Multiple signal pathways in obesity-associated cancer
- (2011) J. Chen Obesity Reviews
- The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer
- (2011) Jatin Roper et al. PLoS One
- Treatment of Metastatic Colorectal Cancer
- (2011) Janine M. Davies et al. SEMINARS IN ONCOLOGY
- NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
- (2010) S. S. Sikandar et al. CANCER RESEARCH
- Targeting Wnt Signaling in Colon Cancer Stem Cells
- (2010) E. M. F. de Sousa et al. CLINICAL CANCER RESEARCH
- Combination Therapy Targeting Both Tumor-Initiating and Differentiated Cell Populations in Prostate Carcinoma
- (2010) A. Dubrovska et al. CLINICAL CANCER RESEARCH
- Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells
- (2010) Monica Bartucci et al. ENDOCRINE-RELATED CANCER
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
- (2009) N. A. Dallas et al. CANCER RESEARCH
- The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-κB signaling pathway in colorectal carcinomas
- (2009) Yuying Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Obesity, the PI3K/Akt signal pathway and colon cancer
- (2009) X-F. Huang et al. Obesity Reviews
- CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells
- (2008) Naotsugu Haraguchi et al. ANNALS OF SURGICAL ONCOLOGY
- Human Colon Cancer Stem Cells: A New Paradigm in Gastrointestinal Oncology
- (2008) Bruce M. Boman et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
- (2008) L. Vermeulen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
- (2008) A. Dubrovska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Is Src the key to understanding metastasis and developing new treatments for colon cancer?
- (2008) Jiezhong Chen Nature clinical practice. Gastroenterology & hepatology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now